What is Barclays's price target for BYND?

Barclays's latest stated price target for Beyond Meat Inc. (BYND) is $10, from its action on Nov 28, 2022.

What is Barclays's rating on BYND?

Barclays rates BYND Underweight, a bearish rating, as of Nov 28, 2022.

When did Barclays last change its view on BYND?

On Nov 28, 2022, Barclays downgrades to Underweight from Equal Weight, price target $13 to $10.

Barclays BYND price target and rating history

Beyond Meat Inc. (BYND) · Consumer Staples

Barclays rates Beyond Meat Inc. (BYND) Underweight with a $10 price target, as of its latest action on Nov 28, 2022. It has published 4 rating actions on BYND since October 2021, including 1 upgrade and 2 downgrades.

Current rating: Underweight
Price target: $10
Median target, all firms: Too few
Actions on BYND: 4

Barclays price target on BYND

Barclays price target on BYND, each point a stated target, October 2021 to November 2022. Targets before November 2022 (divided by 2) are adjusted for a stock split, going by the prior target Barclays restated.

Every Barclays rating on BYND

Nov 28, 2022
DowngradeBarclays downgrades to Underweight from Equal Weight, price target $13 to $10
May 12, 2022
DowngradeBarclays downgrades to Equal Weight from Overweight, price target $80 to $25
Jan 31, 2022
UpgradeBarclays upgrades to Overweight from Underweight, price target $70 to $80
Oct 25, 2021
ReiterateBarclays cuts its price target to $80 from $90, keeps Underweight

Questions about Barclays and BYND

What is Barclays's price target for BYND?: Barclays's latest stated price target for Beyond Meat Inc. (BYND) is $10, from its action on Nov 28, 2022.
What is Barclays's rating on BYND?: Barclays rates BYND Underweight, a bearish rating, as of Nov 28, 2022.
When did Barclays last change its view on BYND?: On Nov 28, 2022, Barclays downgrades to Underweight from Equal Weight, price target $13 to $10.

More BYND rating histories

All Barclays ratings BYND news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.